Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/15/25
End: 05/31/27
Due: 05/31/28
Phase: N/A
Priority: Normal
Start: 09/10/21
End: 07/31/24
Due: 07/31/25
Phase: N/A
Priority: Normal
Start: 08/02/23
End: 06/30/29
Due: 06/30/30
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Neoadjuvant Therapy （NALIRIFOX） for Locally Advanced Colon and Upper Rectal Cancer | NCT07020468 | Affiliated Cancer Hospital of Shantou University Medical College | user2@example.com | None | 2025-05-15 | 2027-05-31 | 2028-05-31 | - | - | 2025-07-14 |
| Effect of Tramadol on Postoperative Sore Throat After General Anesthesia | NCT04991493 | Affiliated Cancer Hospital of Shantou University Medical College | user2@example.com | None | 2021-09-10 | 2024-07-31 | 2025-07-31 | - | - | 2025-07-14 |
| Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell Carcinoma | NCT05984342 | Affiliated Cancer Hospital of Shantou University Medical College | user2@example.com | None | 2023-08-02 | 2029-06-30 | 2030-06-30 | - | - | 2025-07-14 |